Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 06-2014 | |
| Sales | 4,948 | 2,783 | 2,728 | 0 | 0 |
| Gross Profit | 4,948 | 2,783 | 2,728 | N/A | N/A |
| Operating Expenses | 13,256 | 13,890 | 8,335 | 0 | 0 |
| Operating Income | -8,308 | -11,107 | -5,607 | N/A | N/A |
| Other Income | 2,086 | -3,314 | 3,713 | 0 | 0 |
| Pre-tax Income | -6,222 | -14,421 | -1,894 | 0 | 0 |
| Income Tax | 20 | 147 | 51 | N/A | N/A |
| Net Income Continuous | -6,242 | -14,568 | -1,945 | N/A | N/A |
| Net Income | $-6,242 | $-14,568 | $-1,945 | $N/A | $N/A |
| EPS Basic Total Ops | -0.06 | -0.30 | -0.30 | N/A | N/A |
| EPS Basic Continuous Ops | -0.09 | -0.28 | -0.06 | N/A | N/A |
| EPS Diluted Total Ops | -0.06 | -0.30 | -0.30 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.09 | -0.28 | -0.06 | N/A | N/A |
| EBITDA(a) | $-7,820 | $-10,810 | $-5,539 | $N/A | $N/A |